Skip to content

PROCEPT BioRobotics Corporation PRCT Increase (Decrease) in Other Operating Assets

Increase (Decrease) in Other Operating Assets at other companies

Boston Scientific logo
Boston ScientificBSX
$109M+41.6%
iRadimed logo
iRadimedIRMD
-$13K-286%
Oceaneering International logo
Oceaneering InternationalOII
$8.84M+338%

Other financials

Income statement

See full
Revenue$83.1M+20.2%
Gross profit$53.9M+22.2%
Operating income-$32.6M-18.8%
Net income-$31.6M-27.9%
EPS (diluted)-$0.56-24.4%

Balance sheet

See full
Cash & equivalents$12.2M-96.2%
Total debt$78.0M-11.8%
Total equity$347.7M-10.7%
Total assets$487.1M-6.2%

Cash flow

See full
Operating cash flow-$38.1M-125%
CapEx$2.9M+58.7%
Free cash flow-$41.0M-118%

Valuation

See full
Market cap$1.19B-24.8%
Enterprise value$1.25B
P/S3.7×

Profitability

See full
Gross margin64%+1.3pp
Operating margin-33.9%-3.8pp
Net margin-31.8%-3.4pp
FCF margin-25%-5.7pp

Returns & leverage

See full
Return on equity-27.8%+0.2pp
Debt / equity0.2×0.0×
Current ratio6.7×-2.2×

Where this comes from

Reported directly by PROCEPT BioRobotics Corporation in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingAssets.

The official record: PROCEPT BioRobotics Corporation’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about PROCEPT BioRobotics Corporation's increase (decrease) in other operating assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PROCEPT BioRobotics Corporation's increase (decrease) in other operating assets?
PROCEPT BioRobotics Corporation (PRCT) reported increase (decrease) in other operating assets of $431K in Q1 2026.
How has PROCEPT BioRobotics Corporation's increase (decrease) in other operating assets changed year-over-year?
PROCEPT BioRobotics Corporation's increase (decrease) in other operating assets increased by 9.1% year-over-year, from $395K to $431K.
What is the long-term trend for PROCEPT BioRobotics Corporation's increase (decrease) in other operating assets?
Over 3 years (2022 to 2025), PROCEPT BioRobotics Corporation's increase (decrease) in other operating assets has grown at a 284.3% compound annual growth rate (CAGR), from $51K to $2.9M.
What does increase (decrease) in other operating assets mean?
This captures the net change in miscellaneous assets that are not classified as loans, securities, or property, plant, and equipment. It often includes items like accrued interest receivables, prepaid expenses, and other short-term operational assets.